DE69323465T2 - Sulfatase-ähnliches Protein aus Knochen und Verfahren zu dessen Herstellung - Google Patents

Sulfatase-ähnliches Protein aus Knochen und Verfahren zu dessen Herstellung

Info

Publication number
DE69323465T2
DE69323465T2 DE69323465T DE69323465T DE69323465T2 DE 69323465 T2 DE69323465 T2 DE 69323465T2 DE 69323465 T DE69323465 T DE 69323465T DE 69323465 T DE69323465 T DE 69323465T DE 69323465 T2 DE69323465 T2 DE 69323465T2
Authority
DE
Germany
Prior art keywords
bone
protein
osf
metabolic diseases
sulfatase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69323465T
Other languages
English (en)
Other versions
DE69323465D1 (de
Inventor
Sunao Takeshita
Toshimi Ito
Yoko Otawara-Hamamoto
Egon Amann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel
Publication of DE69323465D1 publication Critical patent/DE69323465D1/de
Application granted granted Critical
Publication of DE69323465T2 publication Critical patent/DE69323465T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69323465T 1992-08-28 1993-08-25 Sulfatase-ähnliches Protein aus Knochen und Verfahren zu dessen Herstellung Expired - Fee Related DE69323465T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23003092 1992-08-28
JP4324034A JPH06121678A (ja) 1992-08-28 1992-12-03 骨関連サルファターゼ様タンパク質およびその製造法

Publications (2)

Publication Number Publication Date
DE69323465D1 DE69323465D1 (de) 1999-03-25
DE69323465T2 true DE69323465T2 (de) 1999-08-19

Family

ID=26529110

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69323465T Expired - Fee Related DE69323465T2 (de) 1992-08-28 1993-08-25 Sulfatase-ähnliches Protein aus Knochen und Verfahren zu dessen Herstellung

Country Status (9)

Country Link
US (1) US5627050A (de)
EP (1) EP0590309B1 (de)
JP (1) JPH06121678A (de)
AT (1) ATE176685T1 (de)
AU (1) AU663215B2 (de)
CA (1) CA2104995A1 (de)
DE (1) DE69323465T2 (de)
DK (1) DK0590309T3 (de)
ES (1) ES2130198T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3472587B2 (ja) * 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030195162A1 (en) * 1999-09-17 2003-10-16 Cohn Daniel H. Genetic marker for spondyloepimetaphyseal dysplasia
AU2003201160A1 (en) * 2002-01-14 2003-07-24 Bayer Aktiengesellschaft Regulation of human sulfatase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2041280A1 (en) * 1990-05-10 1991-11-11 Yosuke Sawada Arylsulfatase
JP3560252B2 (ja) * 1992-08-28 2004-09-02 アベンティス ファーマ株式会社 骨関連カドヘリン様タンパク質およびその製造法
JP3472587B2 (ja) * 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法

Also Published As

Publication number Publication date
EP0590309A3 (de) 1995-02-15
JPH06121678A (ja) 1994-05-06
DE69323465D1 (de) 1999-03-25
US5627050A (en) 1997-05-06
DK0590309T3 (da) 1999-09-20
EP0590309A2 (de) 1994-04-06
AU663215B2 (en) 1995-09-28
AU4492193A (en) 1994-03-03
EP0590309B1 (de) 1999-02-10
CA2104995A1 (en) 1994-03-01
ES2130198T3 (es) 1999-07-01
ATE176685T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
DE60029566D1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
DK0881908T3 (da) Anvendelse af fiberblastvækstfaktorer til stimulering af knoglevækst
EP0888787A2 (de) Medizintechnische Vorrichtung zur Verbesserung der Hautfixierung von Dauerkathetern und anderen transcutanen Implantaten bei reduzierter Infektionsgefahr
DE69328527D1 (de) Carboxypeptidase-ähnliches Protein aus Knochen und Verfahren zur dessen Herstellung
DE3690341D2 (en) Bone cement
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
DE69323465D1 (de) Sulfatase-ähnliches Protein aus Knochen und Verfahren zu dessen Herstellung
ATE208420T1 (de) Protein des cadherin-typs aus knochen und verfahren zur herstellung
SE9003887L (sv) Cellproliferationsmatris och anvaendning daerav
PT83309A (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
Stirling The report of an investigation into the process of the healing of fractured bones, with some clinical applications
ATE16189T1 (de) Verfahren zur herstellung von menschlichen fetten und von lacto-n-norhexaosyl keramide.
MW4190A1 (en) Compounds
PT100075A (pt) Acidos aril- ou arilalquil-acil-amino-alquil-hidroxidifosfonicos, um processo para a sua preparacao e sua utilizacao na terapia de perturbacoes do tecido osteoarticular e conjuntivo
SU978184A1 (ru) Способ моделировани остеомиелита
Toyoumi et al. Results of Treatment for Patellar Fractures
WILLIS IN VITRO STIMULATION OF COLLAGEN SYNTHESIS BY PURIFIED SOMATOMEDIN IN CHONDROSARCOMA CHONDROCYTES.
DE3807352A1 (de) Verwendung von dopamin-agonisten zur behandlung von knochenverletzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee